About

Rebidez-DSR

Product Description

A sustained-release tablet combining the proton pump inhibitor (PPI) Rabeprazole and the antiemetic and prokinetic agent Domperidone. This unique formulation provides relief from gastroesophageal reflux disease (GERD) symptoms, peptic ulcers, and associated gastrointestinal disorders.

Key Ingredients

Rabeprazole A PPI that reduces stomach acid production, alleviating symptoms of GERD, peptic ulcers, and Zollinger-Ellison syndrome.

Domperidone An antiemetic and prokinetic agent that helps regulate gastrointestinal motility, reducing nausea, vomiting, and symptoms of gastroparesis.

Ingredients

This combination product is indicated for:
Gastroesophageal Reflux Disease (GERD): Relieves symptoms of heartburn, regurgitation, and difficulty swallowing.

Peptic Ulcers: Treats and prevents ulcers in the stomach and duodenum.

Zollinger-Ellison Syndrome: Reduces excessive stomach acid production.

Gastroparesis: Relieves symptoms of nausea, vomiting, and abdominal bloating.

Dyspepsia: Treats symptoms of indigestion, bloating, and discomfort.

Dosage

TTake one tablet once daily, preferably in the morning, before meals.